These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15199517)

  • 1. Venous thromboembolic disease: risk factors and laboratory investigation.
    Alhenc-Gelas M; Aiach M; de Moerloose P
    Semin Vasc Med; 2001; 1(1):81-8. PubMed ID: 15199517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
    Reitsma PH; van de Stolpe A
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilia and risk of venous thrombosis in patients with cancer.
    Decousus H; Moulin N; Quenet S; Bost V; Rivron-Guillot K; Laporte S; Mismetti P
    Thromb Res; 2007; 120 Suppl 2():S51-61. PubMed ID: 18023713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital and acquired activated protein C resistance.
    Nicolaes GA; Dahlbäck B
    Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk factors of venous thrombosis.
    Franco RF; Reitsma PH
    Hum Genet; 2001 Oct; 109(4):369-84. PubMed ID: 11702218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden with deep venous thrombosis.
    Gardner J
    Clin Lab Sci; 2003; 16(1):6-9. PubMed ID: 12587652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic risk factors of venous thromboembolism].
    Oner F; Kaya A; Doğan R; Numanoğlu N
    Tuberk Toraks; 2003; 51(1):60-9. PubMed ID: 15100907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of thrombophilia]].
    Kemkes-Matthes B
    Zentralbl Chir; 2001 Jun; 126(6):433-7. PubMed ID: 11446062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant proteins in childhood venous and arterial thrombosis: a review.
    Segel GB; Francis CA
    Blood Cells Mol Dis; 2000 Oct; 26(5):540-60. PubMed ID: 11112387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
    Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
    Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
    Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
    Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
    Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis.
    Chegeni R; Kazemi B; Hajifathali A; Pourfathollah A; Lari GR
    Thromb Res; 2007; 119(2):189-93. PubMed ID: 16542711
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of thrombotic children with malignancy.
    Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
    Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombophilia risk factors evaluation in a group of Italian patients with deep venous thrombosis].
    Valverde S; Antico F; Trabuio E; Basso D; Navaglia F; Orlandini E; Giacomini A; Manoni F; Gessoni G
    Recenti Prog Med; 2008; 99(7-8):348-53. PubMed ID: 18751613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
    Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Venous thromboembolic disease: which coagulation screening, for whom, when?].
    Wautrecht JC
    Rev Med Brux; 2005 Sep; 26(4):S315-9. PubMed ID: 16240880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.